UK markets open in 7 hours 38 minutes

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.750.00 (0.00%)
At close: 09:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 59.78B
Enterprise value 77.13B
Trailing P/E 11.61
Forward P/E 9.29
PEG ratio (5-yr expected) 1.35
Price/sales (ttm)1.44
Price/book (mrq)3.28
Enterprise value/revenue 2.07
Enterprise value/EBITDA 7.77

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 3-21.17%
S&P500 52-week change 3-15.36%
52-week high 323.47
52-week low 313.48
50-day moving average 316.94
200-day moving average 320.28

Share statistics

Avg vol (3-month) 315.91k
Avg vol (10-day) 36k
Shares outstanding 54.07B
Implied shares outstanding 6N/A
Float 83.92B
% held by insiders 10.70%
% held by institutions 143.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.11
Forward annual dividend yield 47.51%
Trailing annual dividend rate 30.86
Trailing annual dividend yield 35.85%
5-year average dividend yield 45.36
Payout ratio 482.42%
Dividend date 312 Apr 2017
Ex-dividend date 417 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 12.24%
Operating margin (ttm)23.48%

Management effectiveness

Return on assets (ttm)6.58%
Return on equity (ttm)24.71%

Income statement

Revenue (ttm)37.24B
Revenue per share (ttm)9.28
Quarterly revenue growth (yoy)18.70%
Gross profit (ttm)22.66B
EBITDA 11.11B
Net income avi to common (ttm)4.57B
Diluted EPS (ttm)1.27
Quarterly earnings growth (yoy)-39.90%

Balance sheet

Total cash (mrq)6.53B
Total cash per share (mrq)1.62
Total debt (mrq)22.11B
Total debt/equity (mrq)97.67
Current ratio (mrq)1.43
Book value per share (mrq)4.07

Cash flow statement

Operating cash flow (ttm)10.51B
Levered free cash flow (ttm)-9.89B